Tau Conformational State-Specific Nanobody Targeting
🧪 Overview
Deploy engineered nanobodies that selectively bind pathological tau conformations present in vesicles while avoiding physiological tau. These nanobodies would be conjugated to membrane-permeable peptides and designed to recognize misfolded tau epitopes exposed only in disease states.
Debate provenance: derived from debate `sess_SDA-2026-04-08-gap-debate-20260406-062052-81a54bfd` on question: The debate identified fundamental druggability challenges for these targets due to their essential roles, but specific molecular approaches to achieve selectivity for tau-containing vesicles versus normal cellular functions were not resolved. Novel targeting strategies are needed.
Source: Debate se. Consensus signal: domain_expert, skeptic, synthesizer, theorist discussed the mechanism terms Conformational, MAPT, Nanobody, State-Specific, Targeting. Novelty signal: skeptic-discussed-with-qualified-concession.
🧬 Mechanism
Auto-built from this analysis's top knowledge-graph edges.
graph TD
MAPT["MAPT"] -->|modulates| autophagy_pathway["autophagy pathway"]
MAPT_1["MAPT"] -->|interacts with| MAP1LC3A["MAP1LC3A"]
HSP70_modulators["HSP70 modulators"] -.->|inhibits| MAPT_aggregation["MAPT aggregation"]
HSP90_inhibitors["HSP90 inhibitors"] -->|modulates| MAPT_2["MAPT"]
HSPA1A["HSPA1A"] -->|selectively target| mis_folded_MAPT["mis folded MAPT"]
MAPT_3["MAPT"] -->|causes| membrane_lipid_asymmetry["membrane lipid asymmetry"]
MAPT_4["MAPT"] -->|disrupts| vesicular_pH_homeostasis["vesicular pH homeostasis"]
MAPT_5["MAPT"] -->|causes| phosphatidylserine_exposu["phosphatidylserine exposure"]
nanobodies["nanobodies"] -->|selectively target| pathological_MAPT_conform["pathological MAPT conformations"]
MAPT_6["MAPT"] -->|causes| vesicle_surface_glycoprot["vesicle surface glycoprotein alterations"]
style MAPT fill:#4fc3f7,stroke:#333,color:#000
style autophagy_pathway fill:#81c784,stroke:#333,color:#000
style MAPT_1 fill:#4fc3f7,stroke:#333,color:#000
style MAP1LC3A fill:#4fc3f7,stroke:#333,color:#000
style HSP70_modulators fill:#4fc3f7,stroke:#333,color:#000
style MAPT_aggregation fill:#4fc3f7,stroke:#333,color:#000
style HSP90_inhibitors fill:#4fc3f7,stroke:#333,color:#000
style MAPT_2 fill:#4fc3f7,stroke:#333,color:#000
style HSPA1A fill:#4fc3f7,stroke:#333,color:#000
style mis_folded_MAPT fill:#4fc3f7,stroke:#333,color:#000
style MAPT_3 fill:#4fc3f7,stroke:#333,color:#000
style membrane_lipid_asymmetry fill:#4fc3f7,stroke:#333,color:#000
style MAPT_4 fill:#4fc3f7,stroke:#333,color:#000
style vesicular_pH_homeostasis fill:#4fc3f7,stroke:#333,color:#000
style MAPT_5 fill:#4fc3f7,stroke:#333,color:#000
style phosphatidylserine_exposu fill:#4fc3f7,stroke:#333,color:#000
style nanobodies fill:#4fc3f7,stroke:#333,color:#000
style pathological_MAPT_conform fill:#4fc3f7,stroke:#333,color:#000
style MAPT_6 fill:#4fc3f7,stroke:#333,color:#000
style vesicle_surface_glycoprot fill:#4fc3f7,stroke:#333,color:#000⚖️ Evidence
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — MAPT
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for MAPT.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
📊 Market Indicators
💾 Resource Usage
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_round_mining
| source | v1_phase_c_backfill |
| origin_type | debate_round_mining |
| _schema_version | 1 |